RhumbLine Advisers’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4177 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4291 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4381 |
|
|
2024
Q1 | – | Sell |
-66
| Closed | -$164 | – | 4259 |
|
|
2023
Q4 | $164 | Hold |
66
| – | – | ﹤0.01% | 4240 |
|
|
2023
Q3 | $216 | Hold |
66
| – | – | ﹤0.01% | 4265 |
|
|
2023
Q2 | $304 | Buy |
+66
| New | +$304 | ﹤0.01% | 4339 |
|
|
2022
Q2 | – | Sell |
-3,018
| Closed | -$90K | – | 3193 |
|
|
2022
Q1 | $90K | Buy |
3,018
+143
| +5% | +$4.26K | ﹤0.01% | 2905 |
|
|
2021
Q4 | $125K | Sell |
2,875
-274
| -9% | -$11.9K | ﹤0.01% | 2913 |
|
|
2021
Q3 | $224K | Sell |
3,149
-207
| -6% | -$14.7K | ﹤0.01% | 2868 |
|
|
2021
Q2 | $385K | Buy |
3,356
+805
| +32% | +$92.4K | ﹤0.01% | 2677 |
|
|
2021
Q1 | $265K | Buy |
2,551
+197
| +8% | +$20.5K | ﹤0.01% | 2744 |
|
|
2020
Q4 | $112K | Buy |
2,354
+652
| +38% | +$31K | ﹤0.01% | 2957 |
|
|
2020
Q3 | $47K | Sell |
1,702
-153
| -8% | -$4.23K | ﹤0.01% | 2952 |
|
|
2020
Q2 | $71K | Buy |
1,855
+963
| +108% | +$36.9K | ﹤0.01% | 3005 |
|
|
2020
Q1 | $44K | Hold |
892
| – | – | ﹤0.01% | 2871 |
|
|
2019
Q4 | $40K | Hold |
892
| – | – | ﹤0.01% | 2920 |
|
|
2019
Q3 | $37K | Sell |
892
-10
| -1% | -$415 | ﹤0.01% | 2937 |
|
|
2019
Q2 | $45K | Buy |
+902
| New | +$45K | ﹤0.01% | 2958 |
|